메뉴 건너뛰기




Volumn 94, Issue 2, 2009, Pages 239-248

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins

Author keywords

ABO blood group incompatibility; Allogeneic hematopoietic stem cell transplantation; Pure red cell aplasia

Indexed keywords

AGGLUTININ;

EID: 59449100339     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13356     Document Type: Article
Times cited : (68)

References (73)
  • 1
    • 0025915046 scopus 로고
    • Immunohematologic complications of bone marrow transplantation
    • Klumpp TR. Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 1991;8:159-70.
    • (1991) Bone Marrow Transplant , vol.8 , pp. 159-170
    • Klumpp, T.R.1
  • 2
    • 28744440859 scopus 로고    scopus 로고
    • ABO blood group barrier in allogeneic bone marrow transplantation revisited. GVHD Working Committee of Center for International Blood and Marrow Transplant Research
    • Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. GVHD Working Committee of Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2005;11:1006-13.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 1006-1013
    • Seebach, J.D.1    Stussi, G.2    Passweg, J.R.3    Loberiza Jr, F.R.4    Gajewski, J.L.5    Keating, A.6
  • 4
    • 0027052260 scopus 로고
    • Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow
    • Schanz U, Gmur J. Rapid and automated processing of bone marrow grafts without Ficoll density gradient for transplantation of cryopreserved autologous or ABO-incompatible allogeneic bone marrow. Bone Marrow Transplant 1992;1: 507-13.
    • (1992) Bone Marrow Transplant , vol.1 , pp. 507-513
    • Schanz, U.1    Gmur, J.2
  • 5
    • 0021932013 scopus 로고
    • Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch
    • Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 1985;48:89-104.
    • (1985) Vox Sang , vol.48 , pp. 89-104
    • Warkentin, P.I.1    Hilden, J.M.2    Kersey, J.H.3    Ramsay, N.K.4    McCullough, J.5
  • 6
    • 0029162730 scopus 로고
    • Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility
    • Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Schönitzer D, Nachbaur D, et al. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Transfusion 1995; 3:592-5.
    • (1995) Transfusion , vol.3 , pp. 592-595
    • Nussbaumer, W.1    Schwaighofer, H.2    Gratwohl, A.3    Kilga, S.4    Schönitzer, D.5    Nachbaur, D.6
  • 7
    • 4444262896 scopus 로고    scopus 로고
    • ABO-incompatible bone marrow transplantation: A GITMO survey of current practice in Italy and comparison with the literature
    • Raimondi R, Soli M, Lamparelli T, Bacigalupo A, Arcese W, Belloni M, et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 2004;34: 321-9.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 321-329
    • Raimondi, R.1    Soli, M.2    Lamparelli, T.3    Bacigalupo, A.4    Arcese, W.5    Belloni, M.6
  • 9
    • 0003809510 scopus 로고    scopus 로고
    • 15 ed. Bethesda: American Association of Blood Banking
    • Brecher M. Technical Manual. 15 ed. Bethesda: American Association of Blood Banking, 2005.
    • (2005) Technical Manual
    • Brecher, M.1
  • 10
    • 33645294126 scopus 로고    scopus 로고
    • Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Xenotransplantation 2006;13:126-32.
    • Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Xenotransplantation 2006;13:126-32.
  • 11
    • 0025021870 scopus 로고
    • Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation
    • Gmür JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D, Metaxas M. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990;75:290-5.
    • (1990) Blood , vol.75 , pp. 290-295
    • Gmür, J.P.1    Burger, J.2    Schaffner, A.3    Neftel, K.4    Oelz, O.5    Frey, D.6    Metaxas, M.7
  • 12
    • 20044369903 scopus 로고    scopus 로고
    • Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation
    • Griffith LM, McCoy JP Jr, Bolan CD, Stroncek DF, Pickett AC, Linton GF, et al. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005;128:668-75.
    • (2005) Br J Haematol , vol.128 , pp. 668-675
    • Griffith, L.M.1    McCoy Jr, J.P.2    Bolan, C.D.3    Stroncek, D.F.4    Pickett, A.C.5    Linton, G.F.6
  • 14
    • 0023553002 scopus 로고
    • Evidence for different kinds of major ABO incompatibility in transplantation due to the interplay of qualitative and quantitative factors: Application to the management of 62 bone marrow recipients
    • Reviron J, Schenmetzler C, Bussel A, Devergie A, Gluckman E. Evidence for different kinds of major ABO incompatibility in transplantation due to the interplay of qualitative and quantitative factors: application to the management of 62 bone marrow recipients. Transplant Proc 1987;19:4623-8.
    • (1987) Transplant Proc , vol.19 , pp. 4623-4628
    • Reviron, J.1    Schenmetzler, C.2    Bussel, A.3    Devergie, A.4    Gluckman, E.5
  • 15
    • 0019945328 scopus 로고
    • Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion
    • Braine HG, Sensenbrenner LL, Wright SK, Tutschka PJ, Saral R, Santos GW. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 1982;60:420-5.
    • (1982) Blood , vol.60 , pp. 420-425
    • Braine, H.G.1    Sensenbrenner, L.L.2    Wright, S.K.3    Tutschka, P.J.4    Saral, R.5    Santos, G.W.6
  • 16
    • 0025615516 scopus 로고
    • Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation
    • Volin L, Ruutu T. Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation. Acta Haematol 1990;84:195-7.
    • (1990) Acta Haematol , vol.84 , pp. 195-197
    • Volin, L.1    Ruutu, T.2
  • 18
    • 0031719555 scopus 로고    scopus 로고
    • CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation
    • Selleri C, Raiola A, De Rosa G, Luciano L, Pezzullo L, Picardi M, Rotoli B. CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation. Bone Marrow Transplant 1998;22: 605-7.
    • (1998) Bone Marrow Transplant , vol.22 , pp. 605-607
    • Selleri, C.1    Raiola, A.2    De Rosa, G.3    Luciano, L.4    Pezzullo, L.5    Picardi, M.6    Rotoli, B.7
  • 19
    • 0024422350 scopus 로고
    • Antibody-mediated marrow failure after allogeneic bone marrow transplantation
    • Barge AJ, Johnson G, Witherspoon R, Torok-Storb B. Antibody-mediated marrow failure after allogeneic bone marrow transplantation. Blood 1989;74:1477-80.
    • (1989) Blood , vol.74 , pp. 1477-1480
    • Barge, A.J.1    Johnson, G.2    Witherspoon, R.3    Torok-Storb, B.4
  • 20
    • 0033753941 scopus 로고    scopus 로고
    • Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning
    • Veelken H, Wäsch R, Behringer D, Bertz H, Finke J. Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning. Bone Marrow Transplant 2000;26: 911-5.
    • (2000) Bone Marrow Transplant , vol.26 , pp. 911-915
    • Veelken, H.1    Wäsch, R.2    Behringer, D.3    Bertz, H.4    Finke, J.5
  • 21
    • 18744415128 scopus 로고    scopus 로고
    • Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation
    • Maciej Zaucha J, Mielcarek M, Takatu A, Little MT, Gooley T, Baker J, et al. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. Br J Haematol 2002;119:740-50.
    • (2002) Br J Haematol , vol.119 , pp. 740-750
    • Maciej Zaucha, J.1    Mielcarek, M.2    Takatu, A.3    Little, M.T.4    Gooley, T.5    Baker, J.6
  • 22
    • 0023573243 scopus 로고
    • Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): Quantitative and kinetic aspects in 58 BMTs
    • Reviron J, Schenmetzler C, Bussel A, Frappaz D, Devergie A, Gluckman E. Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs. Transplant Proc 1987;19: 4618-22.
    • (1987) Transplant Proc , vol.19 , pp. 4618-4622
    • Reviron, J.1    Schenmetzler, C.2    Bussel, A.3    Frappaz, D.4    Devergie, A.5    Gluckman, E.6
  • 23
    • 0023832322 scopus 로고
    • Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
    • Sniecinski IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988;45:530-4.
    • (1988) Transplantation , vol.45 , pp. 530-534
    • Sniecinski, I.J.1    Oien, L.2    Petz, L.D.3    Blume, K.G.4
  • 25
    • 0033951894 scopus 로고    scopus 로고
    • Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
    • Lee JH, Lee KH, Kim S, Lee JS, Kim SH, Kwon SW, Kim WK. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:179-84.
    • (2000) Bone Marrow Transplant , vol.25 , pp. 179-184
    • Lee, J.H.1    Lee, K.H.2    Kim, S.3    Lee, J.S.4    Kim, S.H.5    Kwon, S.W.6    Kim, W.K.7
  • 26
    • 0034030686 scopus 로고    scopus 로고
    • Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: A major ABO mismatch means problems
    • Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Knöbl P, et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000;40:543-50.
    • (2000) Transfusion , vol.40 , pp. 543-550
    • Worel, N.1    Greinix, H.T.2    Schneider, B.3    Kurz, M.4    Rabitsch, W.5    Knöbl, P.6
  • 27
    • 0035885919 scopus 로고    scopus 로고
    • Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
    • Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.
    • (2001) Blood , vol.98 , pp. 1687-1694
    • Bolan, C.D.1    Leitman, S.F.2    Griffith, L.M.3    Wesley, R.A.4    Procter, J.L.5    Stroncek, D.F.6
  • 28
    • 0036068283 scopus 로고    scopus 로고
    • Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor
    • Kanda Y, Tanosaki R, Nakai K, Saito T, Ohnishi M, Niiya H, et al. Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor. Br J Haematol 2002;118: 128-31.
    • (2002) Br J Haematol , vol.118 , pp. 128-131
    • Kanda, Y.1    Tanosaki, R.2    Nakai, K.3    Saito, T.4    Ohnishi, M.5    Niiya, H.6
  • 29
    • 23744491453 scopus 로고    scopus 로고
    • Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants
    • Damodar S, George B, Mammen J, Mathews V, Srivastava A, Chandy M. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant 2005;36:233-5.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 233-235
    • Damodar, S.1    George, B.2    Mammen, J.3    Mathews, V.4    Srivastava, A.5    Chandy, M.6
  • 30
    • 0036485135 scopus 로고    scopus 로고
    • ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning
    • Badros A, Tricot G, Toor A, Morris C, Guo C, Munshi N, et al. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion 2002;42:205-9.
    • (2002) Transfusion , vol.42 , pp. 205-209
    • Badros, A.1    Tricot, G.2    Toor, A.3    Morris, C.4    Guo, C.5    Munshi, N.6
  • 31
    • 7244220238 scopus 로고    scopus 로고
    • Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning
    • Canals C, Muñiz-Díaz E, Martínez C, Martino R, Moreno I, Ramos A, et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004;44:1603-11.
    • (2004) Transfusion , vol.44 , pp. 1603-1611
    • Canals, C.1    Muñiz-Díaz, E.2    Martínez, C.3    Martino, R.4    Moreno, I.5    Ramos, A.6
  • 32
    • 0036488568 scopus 로고    scopus 로고
    • Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation
    • Zhu KE, Xu Y, Wu D, Zhong J. Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2002;10:61-5.
    • (2002) Zhongguo Shi Yan Xue Ye Xue Za Zhi , vol.10 , pp. 61-65
    • Zhu, K.E.1    Xu, Y.2    Wu, D.3    Zhong, J.4
  • 34
    • 0024460414 scopus 로고
    • Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient
    • Cockerill KJ, Lyding J, Zander AR. Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipient. Eur J Haematol 1989;43: 195-200.
    • (1989) Eur J Haematol , vol.43 , pp. 195-200
    • Cockerill, K.J.1    Lyding, J.2    Zander, A.R.3
  • 35
    • 0026031720 scopus 로고
    • Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin
    • Heyll A, Aul C, Runde V, Arning M, Schneider W, Wernet P. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991;77:906.
    • (1991) Blood , vol.77 , pp. 906
    • Heyll, A.1    Aul, C.2    Runde, V.3    Arning, M.4    Schneider, W.5    Wernet, P.6
  • 36
    • 0025850535 scopus 로고
    • Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis
    • Or R, Naparstek E, Mani N, Slavin S. Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis. Transpl Int 1991;4: 99-102.
    • (1991) Transpl Int , vol.4 , pp. 99-102
    • Or, R.1    Naparstek, E.2    Mani, N.3    Slavin, S.4
  • 38
    • 0027193639 scopus 로고
    • Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: Response to antithymocyte globulin
    • Bierman PJ, Warkentin P, Hutchins MR, Klassen LW. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin. Leuk Lymphoma 1993;9:169-71.
    • (1993) Leuk Lymphoma , vol.9 , pp. 169-171
    • Bierman, P.J.1    Warkentin, P.2    Hutchins, M.R.3    Klassen, L.W.4
  • 39
    • 0027937815 scopus 로고
    • Pure red cell aplasia following peripheral stem cell transplantation: Complete response to a short course of high-dose recombinant human erythropoietin
    • Martelli M, Ponchio L, Beguin Y, Meloni G, Mandelli F, Cazzola M. Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica 1994; 79:456-9.
    • (1994) Haematologica , vol.79 , pp. 456-459
    • Martelli, M.1    Ponchio, L.2    Beguin, Y.3    Meloni, G.4    Mandelli, F.5    Cazzola, M.6
  • 40
    • 0028157462 scopus 로고
    • Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team
    • Ohashi K, Akiyama H, Takamoto S, Tanikawa S, Sakamaki H, Onozawa Y. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team. Bone Marrow Transplant 1994;13:335-6.
    • (1994) Bone Marrow Transplant , vol.13 , pp. 335-336
    • Ohashi, K.1    Akiyama, H.2    Takamoto, S.3    Tanikawa, S.4    Sakamaki, H.5    Onozawa, Y.6
  • 41
    • 0029156370 scopus 로고
    • Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin
    • Roychowdhury DF, Linker CA. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995;16:471-2.
    • (1995) Bone Marrow Transplant , vol.16 , pp. 471-472
    • Roychowdhury, D.F.1    Linker, C.A.2
  • 42
    • 9444277937 scopus 로고    scopus 로고
    • Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: Two case reports of treatment with recombinant human erythropoietin
    • Fujisawa S, Maruta A, Sakai R, Taguchi J, Tomita N, Ogawa K, et al. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin. Transpl Int 1996;9:506-8.
    • (1996) Transpl Int , vol.9 , pp. 506-508
    • Fujisawa, S.1    Maruta, A.2    Sakai, R.3    Taguchi, J.4    Tomita, N.5    Ogawa, K.6
  • 43
    • 0031180456 scopus 로고    scopus 로고
    • Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation
    • Ohta S, Yokoyama H, Ise T, Takasawa K, Wada T, Nakao S, et al. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation. Intern Med 1997;36:487-91.
    • (1997) Intern Med , vol.36 , pp. 487-491
    • Ohta, S.1    Yokoyama, H.2    Ise, T.3    Takasawa, K.4    Wada, T.5    Nakao, S.6
  • 44
    • 0031451084 scopus 로고    scopus 로고
    • Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin
    • Santamaría A, Sureda A, Martino R, Domingo-Albós A, Muñiz-Díaz E, Brunet S. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin. Bone Marrow Transplant 1997;20:1105-7.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 1105-1107
    • Santamaría, A.1    Sureda, A.2    Martino, R.3    Domingo-Albós, A.4    Muñiz-Díaz, E.5    Brunet, S.6
  • 46
    • 6544243897 scopus 로고    scopus 로고
    • Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report
    • Ustün C, Celebi H, Arat M, Ozcan M, Dilek I, Gürman G, et al. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report. Ther Apher 1999;3:275-7.
    • (1999) Ther Apher , vol.3 , pp. 275-277
    • Ustün, C.1    Celebi, H.2    Arat, M.3    Ozcan, M.4    Dilek, I.5    Gürman, G.6
  • 47
    • 0036750861 scopus 로고    scopus 로고
    • Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia
    • Maschan AA, Skorobogatova EV, Balashov DN, Pashanov ED, Trakhtman PE, Schipitzina IP, et al. Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002;30:405-7.
    • (2002) Bone Marrow Transplant , vol.30 , pp. 405-407
    • Maschan, A.A.1    Skorobogatova, E.V.2    Balashov, D.N.3    Pashanov, E.D.4    Trakhtman, P.E.5    Schipitzina, I.P.6
  • 48
    • 0036809638 scopus 로고    scopus 로고
    • Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease
    • Yamaguchi M, Sakai K, Murata R, Ueda M. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease. Bone Marrow Transplant 2002;30:539-41.
    • (2002) Bone Marrow Transplant , vol.30 , pp. 539-541
    • Yamaguchi, M.1    Sakai, K.2    Murata, R.3    Ueda, M.4
  • 49
    • 0346752215 scopus 로고    scopus 로고
    • Pure red cell aplasia with the onset of graft versus host disease
    • Grigg AP, Juneja SK. Pure red cell aplasia with the onset of graft versus host disease. Bone Marrow Transplant 2003;32:1099-101.
    • (2003) Bone Marrow Transplant , vol.32 , pp. 1099-1101
    • Grigg, A.P.1    Juneja, S.K.2
  • 50
    • 1542269745 scopus 로고    scopus 로고
    • Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: Response to reintroduction of cyclosporin
    • Hayden PJ, Gardiner N, Molloy K, Ryan J, Lawler M, McCann SR. Pure red cell aplasia after a major ABO-mismatched bone marrow transplant for chronic myeloid leukaemia: response to reintroduction of cyclosporin. Bone Marrow Transplant 2004;33:459-61.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 459-461
    • Hayden, P.J.1    Gardiner, N.2    Molloy, K.3    Ryan, J.4    Lawler, M.5    McCann, S.R.6
  • 51
    • 9444242668 scopus 로고    scopus 로고
    • Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion
    • Verholen F, Stalder M, Helg C, Chalandon Y. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion. Eur J Haematol 2004;73:441-6.
    • (2004) Eur J Haematol , vol.73 , pp. 441-446
    • Verholen, F.1    Stalder, M.2    Helg, C.3    Chalandon, Y.4
  • 52
    • 33645076522 scopus 로고    scopus 로고
    • Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion
    • Woo HY, Min CK, Lee SM, Cho HS, Kim SY, Lee S, et al. Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion. Eur J Haematol 2006;76:160-3.
    • (2006) Eur J Haematol , vol.76 , pp. 160-163
    • Woo, H.Y.1    Min, C.K.2    Lee, S.M.3    Cho, H.S.4    Kim, S.Y.5    Lee, S.6
  • 53
    • 33745047527 scopus 로고    scopus 로고
    • Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation
    • Deotare UR, Vishwabandya A, Mathews V, George B, Srivastava A, Chandy M. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:1149-50.
    • (2006) Bone Marrow Transplant , vol.37 , pp. 1149-1150
    • Deotare, U.R.1    Vishwabandya, A.2    Mathews, V.3    George, B.4    Srivastava, A.5    Chandy, M.6
  • 54
    • 17044380198 scopus 로고    scopus 로고
    • Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation
    • Sorà F, De Matteis S, Piccirillo N, Chiusolo P, Laurenti L, Putzulu R, et al. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation. Transfusion 2005;45:643-5.
    • (2005) Transfusion , vol.45 , pp. 643-645
    • Sorà, F.1    De Matteis, S.2    Piccirillo, N.3    Chiusolo, P.4    Laurenti, L.5    Putzulu, R.6
  • 55
    • 2942594138 scopus 로고    scopus 로고
    • Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation
    • Au WY, Lie AK, Ma ES, Lau GK, Chan EC, Kwong YL. Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation. Transfusion 2004;44:946-7.
    • (2004) Transfusion , vol.44 , pp. 946-947
    • Au, W.Y.1    Lie, A.K.2    Ma, E.S.3    Lau, G.K.4    Chan, E.C.5    Kwong, Y.L.6
  • 56
    • 0034981642 scopus 로고    scopus 로고
    • Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: A case report and literature review
    • Yang MH, Hsu HC. Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review. Ann Hematol 2001;80:299-301.
    • (2001) Ann Hematol , vol.80 , pp. 299-301
    • Yang, M.H.1    Hsu, H.C.2
  • 57
    • 0026410482 scopus 로고
    • Case report: Isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation
    • Sahovic EA, Flick J, Graham CD, Stuart RK. Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation. Am J Med Sci 1991;302:369-73.
    • (1991) Am J Med Sci , vol.302 , pp. 369-373
    • Sahovic, E.A.1    Flick, J.2    Graham, C.D.3    Stuart, R.K.4
  • 58
    • 1942503216 scopus 로고    scopus 로고
    • Pure red cell aplasia after ABO major-mismatched allogeneic peripheral blood stem cell transplantation successfully treated with plasma exchange and low-dose steroid: Two case reports
    • Tsai HJ, Lin SF, Liu TC, Chang CS, Hsiao HH, Chen TP. Pure red cell aplasia after ABO major-mismatched allogeneic peripheral blood stem cell transplantation successfully treated with plasma exchange and low-dose steroid: two case reports. Kaohsiung J Med Sci 2004; 20:128-32.
    • (2004) Kaohsiung J Med Sci , vol.20 , pp. 128-132
    • Tsai, H.J.1    Lin, S.F.2    Liu, T.C.3    Chang, C.S.4    Hsiao, H.H.5    Chen, T.P.6
  • 59
    • 29144497402 scopus 로고    scopus 로고
    • Treatment of Epstein-Barr virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with rituximab following unrelated cord blood transplantation: A case report and literature review
    • Zhu K, Chen J, Chen S. Treatment of Epstein-Barr virus-associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with rituximab following unrelated cord blood transplantation: a case report and literature review. Hematology 2005;10:365-70.
    • (2005) Hematology , vol.10 , pp. 365-370
    • Zhu, K.1    Chen, J.2    Chen, S.3
  • 60
    • 2442595174 scopus 로고    scopus 로고
    • Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: Possible correlation with prolonged pure red cell aplasia
    • Fujiwara T, Yamada M, Miyamura K, Tomiya Y, Ishizawa K, Harigae H, et al. Fludarabine- and cyclophosphamide-based nonmyeloablative conditioning regimen for transplantation of chronic granulomatous disease: possible correlation with prolonged pure red cell aplasia. Int J Hematol 2004;79:293-7.
    • (2004) Int J Hematol , vol.79 , pp. 293-297
    • Fujiwara, T.1    Yamada, M.2    Miyamura, K.3    Tomiya, Y.4    Ishizawa, K.5    Harigae, H.6
  • 61
    • 0027308841 scopus 로고
    • Pure red cell aplasia following ABO-incompatible bone marrow transplantation: Response to erythropoietin
    • Paltiel O, Cournoyer D, Rybka W. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin. Transfusion 1993;33:418-21.
    • (1993) Transfusion , vol.33 , pp. 418-421
    • Paltiel, O.1    Cournoyer, D.2    Rybka, W.3
  • 62
    • 0242288586 scopus 로고    scopus 로고
    • Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation
    • Rabitsch W, Knöbl P, Greinix H, Prinz E, Kalhs P, Hörl WH, Derfler K. Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation. Nephrol Dial Transplant 2003;18:2405-8.
    • (2003) Nephrol Dial Transplant , vol.18 , pp. 2405-2408
    • Rabitsch, W.1    Knöbl, P.2    Greinix, H.3    Prinz, E.4    Kalhs, P.5    Hörl, W.H.6    Derfler, K.7
  • 64
    • 34547561762 scopus 로고    scopus 로고
    • Pure red-cell aplasia following major and bidirectional ABO-incompatible allogeneic stem-cell transplantation: Recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies
    • Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M, et al. Pure red-cell aplasia following major and bidirectional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Ann Hematol 2007;86:677-83.
    • (2007) Ann Hematol , vol.86 , pp. 677-683
    • Helbig, G.1    Stella-Holowiecka, B.2    Wojnar, J.3    Krawczyk, M.4    Krzemien, S.5    Wojciechowska-Sadus, M.6
  • 65
    • 0344034835 scopus 로고    scopus 로고
    • Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: Removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption
    • Rabitsch W, Knöbl P, Prinz E, Keil F, Greinix H, Kalhs P, et al. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant 2003;32:1015-9.
    • (2003) Bone Marrow Transplant , vol.32 , pp. 1015-1019
    • Rabitsch, W.1    Knöbl, P.2    Prinz, E.3    Keil, F.4    Greinix, H.5    Kalhs, P.6
  • 66
    • 33744967731 scopus 로고    scopus 로고
    • Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, et al. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Haematologica 2005; 90Suppl: ECR33.
    • Helbig G, Stella-Holowiecka B, Krawczyk-Kulis M, Wojnar J, Markiewicz M, Wojciechowska-Sadus M, et al. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Haematologica 2005; 90Suppl: ECR33.
  • 67
    • 1342281282 scopus 로고    scopus 로고
    • Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation
    • Hayes-Lattin B, Seipel TJ, Gatter K, Heinrich MC, Maziarz RT. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol 2004;75: 142-5.
    • (2004) Am J Hematol , vol.75 , pp. 142-145
    • Hayes-Lattin, B.1    Seipel, T.J.2    Gatter, K.3    Heinrich, M.C.4    Maziarz, R.T.5
  • 68
    • 0030763580 scopus 로고    scopus 로고
    • Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion
    • Cohen BJ, Beard S, Knowles WA, Ellis JS, Joske D, Goldman JM, et al. Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 1997;37: 947-52.
    • (1997) Transfusion , vol.37 , pp. 947-952
    • Cohen, B.J.1    Beard, S.2    Knowles, W.A.3    Ellis, J.S.4    Joske, D.5    Goldman, J.M.6
  • 69
    • 0032460511 scopus 로고    scopus 로고
    • Human parvovirus B19 capsid antigen in granulocytes in parvovirus-B19- induced pancytopenia after bone marrow transplantation
    • Kobayashi S, Maruta A, Yamamoto T, Katayama N, Higuchi R, Sakano Y, et al. Human parvovirus B19 capsid antigen in granulocytes in parvovirus-B19- induced pancytopenia after bone marrow transplantation. Acta Haematol 1998;100:195-9.
    • (1998) Acta Haematol , vol.100 , pp. 195-199
    • Kobayashi, S.1    Maruta, A.2    Yamamoto, T.3    Katayama, N.4    Higuchi, R.5    Sakano, Y.6
  • 70
    • 0030905624 scopus 로고    scopus 로고
    • Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: Characterization by PCR and B-cell molecular immunology
    • Söderlund M, Ruutu P, Ruutu T, Asikainen K, Franssila R, Hedman K. Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis 1997;29:129-35.
    • (1997) Scand J Infect Dis , vol.29 , pp. 129-135
    • Söderlund, M.1    Ruutu, P.2    Ruutu, T.3    Asikainen, K.4    Franssila, R.5    Hedman, K.6
  • 71
    • 40649107682 scopus 로고    scopus 로고
    • ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: A single center experience of 221 patients
    • Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S, et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant 2008;14:409-17.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 409-417
    • Resnick, I.B.1    Tsirigotis, P.D.2    Shapira, M.Y.3    Aker, M.4    Bitan, M.5    Samuel, S.6
  • 72
    • 0034254282 scopus 로고    scopus 로고
    • Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect
    • Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000;96:1150-6.
    • (2000) Blood , vol.96 , pp. 1150-1156
    • Mielcarek, M.1    Leisenring, W.2    Torok-Storb, B.3    Storb, R.4
  • 73
    • 0026719176 scopus 로고
    • Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate
    • Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, et al. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992;79:3076-85.
    • (1992) Blood , vol.79 , pp. 3076-3085
    • Gajewski, J.L.1    Petz, L.D.2    Calhoun, L.3    O'Rourke, S.4    Landaw, E.M.5    Lyddane, N.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.